Restricted Sensitivity of FJ-C Staining to Assess Neuronal Degeneration and Death in Preclinical Mouse Studies

Abstract

Fluorescein-derived fluorochromes and anionic dyes such as Fluoro-Jade (FJ) stains have been introduced to facilitate recognition of dying neurons in tissue sections. However, the definition of what is really detected by FJ-based stains and its sensitivity in the detection of neuronal cell death is unclear. In our work, we evaluated the outcome of FJ-C staining in mouse brains from 4 different well-characterized models of neurodegeneration. Neuronal degeneration and loss were highlighted with high sensitivity by FJ-C stain in mice with dysfunctional γ-secretase in the glutamatergic neurons and in mice affected by acute cerebral ischemia. Histopathologically, acute eosinophilic necrosis or “red dead” neurons were associated with FJ-C staining in both settings. Conversely, in mice affected by chronic cerebral microinfarcts due to tumor lysis syndrome as well as in a model of mitochondrial encephalopathy, FJ-C staining failed to detect neuronal death. Histopathologically, these models were characterized by extensive neuronal vacuolation associated with fading neurons (“ghost cells”). Therefore, contrary to the widespread belief that FJ-C stain has high affinity for all degenerating neurons regardless of the underlying cell death mechanism, we observed restricted sensitivity of the technique to specific conditions of neuronal cell death. As such, complementary techniques are essential to evaluate the presence of neurodegeneration in the absence of a positive FJ-C signal.

Keywords

Fluoro-Jade C neurodegeneration neuronal cell death mouse models

Detecting neuronal degeneration is a priority to understand the pathogenesis of neurological diseases and to evaluate the effects of novel drugs on the central nervous system. Historically, pathologists relied heavily on conventional detection methods such as hematoxylin and eosin (HE) and Nissl stains to detect degenerating neurons based on their morphology or changes in staining intensity.^15,27 These methods come with technical challenges and disadvantages including limited sensitivity and ambiguous interpretation of the morphological findings. Thus, the need of a reliable, reproducible, and highly sensitive histochemical marker of neuronal degeneration became apparent.²⁷

Fluorescein-derived fluorochromes and anionic dyes such as Fluoro-Jade (FJ) were introduced in the late 1990s to facilitate the recognition of neuronal degeneration resulting from exposure to a variety of neurotoxic insults.^27,29 Since the discovery of FJ, the analogs Fluoro-Jade B (FJ-B) and C (FJ-C) were developed with an increased affinity and resolution for all the different compartments of degenerating neurons (cell body, dendrites, axons, and terminals).^28,30 FJ dyes were designed specifically to stain only degenerating neurons regardless of the types of neurotoxic insults or trauma, thus reducing the false positive results to a negligible minimum.²⁵ However, information on the biochemical principles that allow these dyes to selectively label dying neurons remains largely unknown.²²

A correct understanding of the usefulness and limitations of FJ dyes in association with morphologic neuronal changes is pivotal to adequately diagnose neuronal loss in different mouse brain conditions. To this aim, here we report the results of a retrospective study investigating the sensitivity of FJ-C in paraffin-embedded brain samples from different experimental mouse models characterized by neuronal degeneration and death or loss. While this stain has been deemed extremely sensitive for neuronal degeneration regardless of the underlying cause,^4,18,30 here we show that its sensitivity is not universal but rather dependent on the specific mechanisms of neurodegeneration.

Materials and Methods

For this study, paraffin-embedded brain samples from different preclinical mouse models were used. These included models of (1) dysfunctional γ-secretase in glutamatergic neurons (experimental model 1; B6.129P2(Cg)-Tg(Camk2a-cre)T29-1Stl Aph1a^tm1Bdes Aph1b^tm1Bdes Aph1c^tm1Bdes/J mice), (2) transient cerebral ischemia (experimental model 2; C57BL/6J mice), (3) cerebral microinfarcts secondary to tumor lysis syndrome (experimental model 3; NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/J mice), and (4) mitochondrial encephalopathy (experimental model 4; B6.129P2(Cg)-Parl^tm1.1Bdes/Ieg mice). The animals were utilized according to the experimental contexts as described in^1,13,16,32 and also reported in Table 1.

Samples were selected based on the reported evidence of brain lesions characterized by neuronal degeneration and neuronal death or loss as previously demonstrated by detailed neuropathological analysis and further confirmed by immunohistochemistry (IHC) for glial and/or neuronal markers. The selection of brain areas for FJ-C staining in the different models reflected the severity of histopathologic changes. Mice with dysfunctional γ-secretase in glutamatergic neurons and mice with mitochondrial encephalopathy were analyzed at serial time points ranging from the initial phase to the late stage of the disease. A single time point was considered for mice with transient cerebral ischemia and mice with cerebral microinfarcts secondary to tumor lysis syndrome (Table 1).

Table 1.

Main Features and Highlights of the Investigations Conducted in Experimental Mouse Models

	Experimental model 1	Experimental model 2	Experimental model 3	Experimental model 4
Mouse strain	B6.129P2(Cg)-Tg(Camk2a-cre)T29-1Stl Aph1a^tm1Bdes Aph1b^tm1Bdes Aph1c^tm1Bdes/J	C57BL/6J	NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/J	B6.129P2(Cg)-Parl^tm1.1Bdes/Ieg
Experimental context	Dysfunctional γ-secretase in excitatory neurons of the forebrain¹	Transient cerebral ischemia¹⁶	Cell line-derived orthotopic allograft model of ALL¹³	Mitochondrial encephalopathy³²
No. of brain samples examined	7	4	3	8
Animal sex	Male, female	Female	Not specified	Male, female
Animal age and/or experimental time point(s_	Germline mutation; analysis performed on 26-, 39-, and 60-week-old animals	12- to 16-week-old; analysis performed 72 hours after induction of brain ischemia	6- to 9-week-old; analysis performed 3 to 4 weeks after orthotopic allotransplantation of leukemic cells	Germline mutation; analysis performed on 3-, 5-, and 7-week-old animals
Sample preservation	Perfusion fixation, 4% PFA	Immersion fixation, 10% NBF	Immersion fixation, 10% NBF	Perfusion fixation, 4% PFA
Main histopathological changes	Cortex, progressive atrophy (developing over several months), acute eosinophilic necrosis (“red dead” neurons)	Hippocampus, acute eosinophilic necrosis (“red dead” neurons)	Various brain regions, TLS with multifocal chromatin emboli and microinfarcts, parenchymal necrosis with fading neurons and “ghost forms”	Various brain regions (mainly in the brainstem), progressive necrotizing encephalopathy, neuronal vacuolation, and fading neurons
IHC glial marker(s)	GFAP and IBA1—evidence of gliosis associated with the lesions	IBA1—evidence of gliosis associated with the lesions	IBA1—evidence of gliosis associated with the lesions	GFAP and IBA1—evidence of gliosis associated with the lesions
IHC neuronal marker(s)	Evidence of neuronal loss (NeuN)	Not performed	Not performed	Evidence of neuronal loss (NeuN)
IHC apoptotic marker(s)	Negative (cleaved caspase 3)	Not performed	Not performed	Negative (cleaved caspase 3; TUNEL)
Transmission electron microscopy	Not performed	Not performed	Not performed	Evidence of mitochondrial damage and neuronal necrosis
Fluoro Jade C	Positive, multifocal neurons throughout the cortex	Positive, pyramidal neurons, CA1 field of the hippocampus	Negative	Negative

Abbreviations: ALL, acute lymphocytic leukemia; TLS, tumor lysis syndrome; GFAP, glial acidic fibrillary protein; IBA1, ionized calcium binding adaptor molecule 1; NeuN, neuronal nuclei.

Table 2 reports the details concerning primary antibodies and procedures used for immunohistochemistry and immunofluorescence. The TUNEL assay was performed using the In Situ Cell Death Detection Kit (Millipore-Sigma, Catalog #11684795910) according to the manufacturer’s instructions. The protocol for transmission electron microscopy is described elsewhere.³² FJ-C staining was performed on 10-μm-thick sections according to manufacturer’s recommendation. (https://www.emdmillipore.com/US/en/product/Fluoro-Jade-C, MM_NF-AG325). DAPI nuclear counterstaining was included in the protocol (Sigma-Aldrich D9542). Paraffin sections of the hippocampus with acute neuronal death from a porcine model of cardiac arrest and cardiopulmonary resuscitation were included as positive control.²¹ Paraffin sections of brains from wild-type mouse littermates (for the 2 genetic models considered in this study) or clinically normal and experimentally naïve C57BL/6J were included as negative controls.

Table 2.

Details Concerning Reagents and Procedures Used for Immunohistochemistry/Immunofluorescence.

Target	Pretreatment	Primary antibody	Secondary antibody	Visualization system
NeuN	HIER pH6; 2100 Antigen Retriever	NeuN, EMD Millipore, MAB377, Ms mAb Working concentration 1:1000 Incubation o/n +4 °C	Alexa Fluor 568 donkey anti-mouse, Molecular Probes A10037 Working concentration 1:200 Incubation 45′ RT	Immunofluorescence
GFAP	HIER pH6; 2100 Antigen Retriever	GFAP, Agilent (DAKO), Z0334, Rb pAb Working concentration 1:1000 Incubation o/n +4 °C	Alexa Fluor 488 donkey anti-rabbit, Molecular Probes A21206 Working concentration 1:200 Incubation 45′ RT	Immunofluorescence
IBA1	HIER pH6; 2100 Antigen Retriever	IBA1, WAKO, 019-19741, Rb pAb Working concentration 1:500 Incubation o/n +4 °C	Alexa Fluor 488 donkey anti-rabbit, Molecular Probes A21206 Working concentration 1:200 Incubation 45′ RT	Immunofluorescence
IBA1	HIER pH6; 2100 Antigen Retriever	IBA1, WAKO, 019-19741, Rb pAb Working concentration 1:1000 Incubation o/n +4 °C	EnVision+/HRP, Dako K400311 Working concentration RTU Incubation 45′ RT	Immunoperoxidase, DAB chromogen reaction (Vector Labs ImmPACT DAB SK-4105)
Cleaved-caspase-3	HIER pH6; 2100 Antigen Retriever	Cleaved caspase-3, CST, #9661, Rb Mab Working concentration 1:500 Incubation o/n +4 °C	EnVision+/HRP, Dako K400311 Working concentration RTU Incubation 45′ RT	Immunoperoxidase, DAB chromogen reaction (Vector Labs ImmPACT DAB SK-4105)

Abbreviations: Rb, rabbit; Ms, mouse; Rt, rat; pAb, polyclonal antibody; mAb, monoclonal antibody; HIER, heat induced epitope retrieval; o/n, overnight; RT, room temperature.

Results

For each experimental model considered in this study, the salient neuropathological changes including the results of FJ-C stain and any additional IHC investigation are summarized in Table 1. Compared to HE, neuronal degeneration and loss were highlighted and enhanced by FJ-C stain in mice with dysfunctional γ-secretase in the glutamatergic neurons and in mice affected by acute cerebral ischemia (Figs. 1, 2). Histopathologically, both these models were characterized by acute eosinophilic necrosis (“red dead” neurons; Fig. 3) with gliosis (Fig. 4). While FJ-C signal was mainly observed within the perikarya of the neurons, individual neurites were also highlighted by the stain in some instances. In mice with dysfunctional γ-secretase, progressive neuronal loss was also confirmed by means of NeuN IHC (Suppl. Fig. S1). In the same model, evaluation of serial brain sections stained with HE and FJ-C demonstrated significantly more FJ-C-positive neurons compared to the “red dead” neurons visible with HE stain (Suppl. Fig. S2).

Figures 1–4.

Mouse model of dysfunctional γ-secretase in excitatory neurons of the forebrain (Figs. 1, 3, and 4) and mouse model of transient cerebral ischemia (Fig. 2); brain, mouse. Figures 1 and 2. Fluorescent labeling of degenerating neurons obtained by Fluoro-Jade C in the cerebral cortex (Fig. 1) and hippocampus (Fig. 2). FJ-C stain (green) with DAPI nuclear counterstain (blue). Figure 3. Histopathologically, acute eosinophilic necrosis (“red dead” neurons) is characterized by neuronal hypereosinophilia, cellular shrinkage, and nuclear pyknosis. Hematoxylin and eosin (HE). Figure 4. Gliosis is evidenced by widespread cytoplasmic immunolabeling with GFAP in the cortex of mutant mice but not wild-type control littermates (Fig. 4, inset). Immunofluorescent staining for GFAP (green) with DAPI nuclear counterstain (blue).

Conversely, in mice affected by chronic cerebral microinfarcts due to tumor lysis syndrome as well as in the model of mitochondrial encephalopathy, degenerated neurons were not stained by FJ-C (Figs. 5, 6) despite the presence of severe parenchymal necrosis with fading neurons (“ghost cells”) as well as extensive neuronal vacuolation (especially in the case of mitochondrial encephalopathy; Figs. 7, 8). Gliosis and neuronal loss were confirmed by IHC (Suppl. Fig. S3) and, in mice with mitochondrial encephalopathy, by electron microscopy (Fig. 9).³² No NeuN staining was performed in mice with cerebral microinfarcts secondary to tumor lysis syndrome.

Figures 5–8.

Mouse model of tumor lysis syndrome (Figs. 5, 7) and mouse model of mitochondrial encephalopathy (Figs. 6, 8); brain, mouse. Figures 5 and 7. FJ-C labeling of degenerating neurons is lacking in mice affected by chronic cerebral microinfarcts caused by the embolization of tumor-derived cellular debris (Fig. 5; Fluorescent staining for FJ-C [green] with DAPI nuclear counterstain [blue]). However, neuronal degeneration with vacuolation and fading (black arrowheads) is evident within the infarcted area with hematoxylin and eosin (HE) stain (Fig. 7). Microemboli (black arrow), composed of chromatin material derived from lysed tumor cells, obstruct the capillary beds at the border of the infarcted area. Figures 6 and 8. A similar lack of FJ-C labeling is observed in mice affected by mitochondrial encephalopathy (Fig. 6; Fluorescent staining for FJ-C [green] with DAPI nuclear counterstain [blue]) despite evidence of extensive neuronal vacuolation and fading (black arrowheads) on HE stain (Fig. 8).

Figure 9.

Mouse model of mitochondrial encephalopathy; brain (thalamus), mouse. Degenerating neurons display partial cytoplasmic rarefaction with loss of intracellular organelles and accumulation of abundant electron-lucent material (white asterisks) compartmentalized by distended membranous profiles (neuronal vacuolization). Neuropil surrounding affected neurons contains an intricate mesh of dendritic projection and myelinated axons (black asterisk). Transmission electron microscopy. Scale bar: 5 μm.

In mice with dysfunctional γ-secretase in the glutamatergic neurons and in mice with mitochondrial encephalopathy, there was no evidence of apoptosis as assessed by the TUNEL assay, or by cleaved-caspase 3 IHC performed at different time points.

Discussion

Neuronal loss represents the ultimate endpoint of neurological diseases associated with neurodegeneration. Upon examination of HE-stained sections, the identification of degenerating or dying neurons at acute stages (sometimes referred to as “red dead” neurons) is based on the recognition of morphologic features that include hypereosinophilic cytoplasm, cellular shrinkage, and nuclear pyknosis and fragmentation.⁸ In addition, the finding of fading cells with pale cytoplasm (so-called “ghost cells”), and the presence of enlarged vacuolated neurons in cases of spongiform encephalopathies and storage diseases, are all morphologies indicative of progressive neuronal degeneration and death.

However, the identification of neuronal degeneration on HE-stained slides provides suboptimal sensitivity. Therefore, selective and unequivocal markers have the potential to improve the accuracy of identifying neuronal necrosis.⁴ The fluorescent dye FJ was introduced in 1997 to aid in the detection and localization of toxicant-induced neuronal degeneration.²⁷ Numerous neuropathological alterations have been demonstrated by using FJ since its discovery. The demonstration of neuronal degeneration with FJ staining has been documented in rodents following exposure to physical trauma,^2,10,36 or to toxic compounds including kainic and domoic acids, the mitochondrial complex II inhibitor 3-nitropropiooinic acid (3-NPA), ibogaine, ketamine, or abuse substances such as phencyclidine, dizocilpine, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.^17,23,27,30 FJ dyes have been also employed for the identification of injured neurons in diverse mouse model of neurodegeneration including epilepsy,³⁴ ALS,³⁵ and Parkinson’s disease.³

In order to improve the strength and long-term stability of fluorescent dyes that bind preferentially to damaged neurons, the next generation of anionic fluorescein derivatives—namely FJ-B²⁸ and FJ-C³⁰—were created. Structurally, all 3 FJ dyes are related. The ability of FJ to stain the entire degenerating neuron, including cell body, dendrites, axon, and axon terminals was maintained in subsequent dyes, in addition to improved resolution and contrast.²² In particular, the qualitative difference in the staining characteristics of FJ-C translates to a stain of maximal contrast and higher affinity for degenerating or dying neurons.

Similarly to the first generation of FJ, these new dyes have also been universally considered to have high affinity for degenerating or dying neurons, regardless of the specific underlying insult or cell death mechanism.^{5,11,24,26,30} Despite the presumed ability of FJ-C to label a broad spectrum of injured and degenerating neuronal cells including mature and immature neurons, neuronal stem/precursor cells and neuroepithelial cells,¹² our work demonstrates that the dye sensitivity is restricted to specific conditions of neuronal cell death. Notably, clear FJ-C positivity was observed in the presence of acute neuronal necrosis (“red dead” neurons) as reported in mice with dysfunctional γ-secretase in the glutamatergic neurons and in mice affected by acute cerebral ischemia (experimental models 1 and 2). Conversely, in mice affected by cerebral microinfarcts (resulting from tumor lysis syndrome) or by mitochondrial encephalopathy (experimental models 3 and 4), fading neurons, and/or neurons exhibiting vacuolar degeneration appeared consistently negative for FJ-C.

The mechanism by which the FJ dyes bind to degenerating or dying neurons is not fully understood. Biochemically, FJ is considered an analogue of eosin. Both are anionic dyes staining acidophilic structures that have a net positive charge.¹⁴ Therefore, considering the characteristic eosinophilic tinctorial properties of acute neuronal necrosis (“red dead” neurons), it can be speculated that the binding affinity of FJ-C is restricted to those conditions characterized by accumulation of positively charged molecules in degenerating or dying neurons. In that context, electrostatic attraction to polyamines produced during tissue degradation (ie, cadaverine, spermidine, and putrescine) has been most recently proposed as a possible biochemical explanation.²⁵ Further supporting this view, FJ dyes are known to label a variety of acidophilic (eosinophilic) tissue structures including amyloid plaques,⁹ Rosenthal fibers,^31,33 gemistocytes,^6,30 apoptotic cells,¹² and red blood cells.³⁰

Interestingly, we also confirmed that the identification of degenerating or dying neurons was enhanced using FJ-C in comparison to routine evaluation using HE stain. As shown in experimental model 1 (dysfunctional γ-secretase in glutamatergic neurons), only scattered degenerating neurons were noted histologically as opposed to the greater degree of neuronal degeneration apparent upon FJ-C stain.

Importantly, our study clearly indicates that distinct forms of neuronal degeneration and death, such as the case of mitochondrial encephalopathy, cannot be identified by FJ-C regardless of the early or late time point analyzed. However, in specific settings, such as brain injury resulting from altered perfusion, timing and stage of neuronal damage might play an important role in determining FJ-C labeling. In mice with acute cerebral ischemia, FJ-C positivity has been associated with “red dead” neurons, which are considered a manifestation of acute neuronal injury. Contrarily, FJ-C labeling was negative in brains of mice with tumor lysis syndrome and cerebral microinfarcts, which are characterized by fading neurons and “ghost forms,” a morphological manifestation of long-term neuronal damage. Taken together, these findings might suggest the inability of FJ-C to recognize acute forms of neuronal degeneration at later time points. Unfortunately, because of the observational nature of our study, these considerations remain speculative and properly planned time course experiments are necessary to address the persistence of FJ-C labeling at different time points after acute neuronal injury.

Last, differences in the staining ability of FJ-C may rely on the involvement of specific cell death pathways and associated molecules for neuronal conditions. Over the last decades, it became apparent that multiple regulated cell death (RCD) mechanisms are involved in the maturation, differentiation, and plasticity of neurons,⁷ as well as in neuronal degeneration and loss in several pathologic conditions of the nervous system. In the Parl-deficient mouse model (experimental model 4), characterized by severe mitochondrial respiratory chain dysfunction due to coenzyme Q10 and complex III deficiency, the negative results of TUNEL and cleaved-caspase 3 in conjunction with evidence of neuronal vacuolization, swelling, and breakdown indicated necrosis as the underlying mechanism of cell death.³² Although the totality of microscopic and ultrastructural changes were indicative of severe necrosis, the results of FJ-C staining were consistently negative. Conversely, FJ-C has been reported to be positive in a toxicological model of mitochondrial neurodegeneration induced by the complex II inhibitor NPA.³⁰ Therefore, FJ-C is not sensitive in recognizing all types of neuronal cell death caused by mitochondrial dysfunction. Moreover, in genetically engineered mice with γ-secretase dysfunction in glutamatergic neurons of the forebrain (experimental model 1), cortical neurodegeneration was corroborated by the identification of FJ-C staining. While the underlying mechanism of the γ-secretase model is not completely understood, impaired proteolysis of long-lived proteins together with alterations in other markers of autophagy have been proposed as possible causes of neuronal injury.^19,20

While all the mouse brain conditions discussed herein exhibited clear microscopic lesions compatible with neuronal degeneration, FJ-C staining was only evident in cases with acute eosinophilic neuronal degeneration or death. In addition, the variable outcome of the FJ-C staining in the presence of neuronal degeneration supports the hypothesis that fluorochrome-based anionic dyes may label substances deriving from specific mechanisms of injury. In conclusion, negativity to FJ-C does not rule out presence of neuronal degeneration and death. Therefore, complementary neuropathological, ultrastructural, and biochemical investigations are essential to identify ongoing neuronal injury and loss.

Supplemental Material

Supplemental Material, Combined_supplemental_materials-Santagostino_et_al - Restricted Sensitivity of FJ-C Staining to Assess Neuronal Degeneration and Death in Preclinical Mouse Studies

Supplemental Material, Combined_supplemental_materials-Santagostino_et_al for Restricted Sensitivity of FJ-C Staining to Assess Neuronal Degeneration and Death in Preclinical Mouse Studies by Sara Francesca Santagostino, Marco Spinazzi and Enrico Radaelli in Veterinary Pathology

Footnotes

Acknowledgments

We would like to thank Dr Bart De Strooper (VIB Center for Brain & Disease Research, Leuven, Belgium, and UK Dementia Research Institute at University College, London, UK) and Dr Fabio Maria Grassi (Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland) for contributing some of the samples included in this work.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

ORCID iD

Sara Francesca Santagostino

Enrico Radaelli

Supplemental material for this article is available online.

References

Acx

Serneels

Radaelli

, et al. Inactivation of γ-secretases leads to accumulation of substrates and non-Alzheimer neurodegeneration. Embo Mol Med. 2017;9(8):1088–1099.

Anderson

Miller

Fugaccia

, et al. Regional distribution of Fluoro-Jade B staining in the hippocampus following traumatic brain injury. Exp Neurol. 2005;193(1):125–130.

Bian

Wei

Shi

, et al. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice. Brain Res. 2007;1150:55–61.

Bolon

Anthony

Butt

, et al. Current pathology techniques: symposium review: advances and issues in neuropathology. Toxicol Pathol. 2008;36(6):871–889.

Bowyer

Schmued

. Fluoro-Ruby labeling prior to an amphetamine neurotoxic insult shows a definitive massive loss of dopaminergic terminals and axons in the caudate-putamen. Brain Res. 2006;1075(1):236–239.

Chidlow

Wood

JPM

Sarvestani

, et al. Evaluation of Fluoro-Jade C as a marker of degenerating neurons in the rat retina and optic nerve. Exp Eye Res. 2009;88(3):426–437.

Galluzzi

Vitale

Aaronson

, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486–541.

Garman

. Histology of the central nervous system. Toxicol Pathol. 2011;39(1):22–35.

Gutiérrez

González-Prieto

García-Bueno

, et al. Alternative method to detect neuronal degeneration and amyloid β accumulation in free-floating brain sections with Fluoro-Jade. ASN Neuro. 2018;10:1759091418784357.

10.

Hellmich

Eidson

Capra

, et al. Injured Fluoro-Jade-positive hippocampal neurons contain high levels of zinc after traumatic brain injury. Brain Res. 2007;1127(1):119–126.

11.

Hopkins

Wang

Schmued

. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res. 2000;864(1):69–80.

12.

Ikenari

Kurata

Satoh

, et al. Evaluation of Fluoro-Jade C staining: specificity and application to damaged immature neuronal cells in the normal and injured mouse brain. Neuroscience. 2020;425:146–156.

13.

Jost

Borga

Radaelli

, et al. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia. J Leukoc Biol. 2016;99(6):1077–1087.

14.

Kiernan

. Histological and Histochemical Methods: Theory and Practice. Scion Publishing; 2008:481.

15.

Krinke

Classen

Vidotto

, et al. Detecting necrotic neurons with Fluoro-Jade stain. Exp Toxicol Pathol. 2001;53(5):365–372.

16.

Lee

Lok

Rosell

, et al. Reduction of hippocampal cell death and proteolytic responses in tissue plasminogen activator knockout mice after transient global cerebral ischemia. Neuroscience. 2007;150(1):50–57.

17.

Liu

Zou

Sadovova

, et al. Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia. Int J Dev Neurosci. 2011;29(3):351–358.

18.

National Toxicology Program. Brain—necrosis. Updated January 2, 2014. Accessed August 11, 2020. https://ntp.niehs.nih.gov/nnl/nervous/brain/necrosis/index.htm

19.

Neely

Green

LaFerla

. Presenilin is necessary for efficient proteolysis through the autophagy-lysosome system in a γ-secretase-independent manner. J Neurosci. 2011;31(1):2781–2791.

20.

Oikawa

Walter

. Presenilins and γ-secretase in membrane proteostasis. Cells. 2019;8(3):209.

21.

Ristagno

Fumagalli

Russo

, et al. Postresuscitation treatment with argon improves early neurological recovery in a porcine model of cardiac arrest. Shock. 2014;41(1):72–78.

22.

Sarkar

Schmued

. Fluoro-Jade Dyes: fluorochromes for the histochemical localization of degenerating neurons. In: Bolon

Butt

, eds. Fundamental Neuropathology for Pathologists and Toxicologists: Principles and Techniques. John Wiley; 2011:171–179.

23.

Scallet

Schmued

Slikker

, et al. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci. 2004;81(2):364–370.

24.

Schmued

. Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res. 2003;974(1–2):127–133.

25.

Schmued

. Development and application of novel histochemical tracers for localizing brain connectivity and pathology. Brain Res. 2016;1645:31–35.

26.

Schmued

. The progression of neuronal, myelin, astrocytic, and immunological changes in the rat brain following exposure to aurothioglucose. Brain Res. 2002;949(1–2):171–177.

27.

Schmued

Albertson

Slikker

. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 1997;751(1):37–46.

28.

Schmued

Hopkins

. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 2000;874(2):123–130.

29.

Schmued

Slikker

Clausing

, et al. D-Fenfluramine produces neuronal degeneration in localized regions of the cortex, thalamus, and cerebellum of the rat. Toxicol Sci. 1999;48(1):100–106.

30.

Schmued

Stowers

Scallet

, et al. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 2005;1035(1):24–31.

31.

Sosunov

McKhann

2nd Goldman

. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease. Acta Neuropathol Commun. 2017;5(1):27.

32.

Spinazzi

Radaelli

Horré

, et al. PARL deficiency in mouse causes complex III defects, coenzyme Q depletion, and Leigh-like syndrome. Proc Natl Acad Sci U S A. 2019;116(1):277–286.

33.

Tanaka

Ochi

Hayashi

, et al. Fluoro-Jade: new fluorescent marker of Rosenthal fibers. Neurosci Lett. 2006;407(2):127–130.

34.

Varvel

Neher

Bosch

, et al. Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus. Proc Natl Acad Sci U S A. 2016;113(38):E5665–E5674.

35.

Yang

Sidman

Taksir

, et al. Relationship between neuropathology and disease progression in the SOD1(G93A) ALS mouse. Exp Neurol. 2011;227(2):287–295.

36.

Zhou

Chen

Gao

, et al. Moderate traumatic brain injury triggers rapid necrotic death of immature neurons in the hippocampus. J Neuropathol Exp Neurol. 2012;71(4):348–359.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.44 MB